|
Group IV: Rapid Growing Mycobacteria (RGM)
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and Figures
Table 1:
The Probability of in vitro Susceptibility of the Major RGM Pathogens
to Various Antimicrobial Agents
Vignettes
Review Article: Mege JL, Meghari S, Honstettre A, Capo
C, Raoult D.
The Two faces of interleukin 10 in human infectious
diseases. Lancet Infectious Diseases 2006:7;557-569.]
Review
Article: Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro
A, Daley C, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment,
and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir
Crit Car Med 2007;175:367-416.
Guideline: An Official ATS/IDSA
Statement: Diagnosis, Treatment, and Prevention of Nontuberculosis
Mycobacterial Diseases. Am J Respir Crit Care Med 2007:175;367-416.
Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR.
Prosthetic Joint Infection Due to Rapidly Growing
Mycobacteria: Report of 8 Cases and Review of the Literature.
Clin Infect Dis 2007;45:687-694.
Furuya EY, et al.
Outbreak of Mycobacterium Abscessus Wound Infections
Among "Lipotourists" from the United States Who Underwent Abdominoplasty in
the Dominican Republic. Clin Infect Dis. 2008 Apr
15;46:1181-8.
E. Peres, et.al..
Mycobacterium Chelonae Necrotizing Pneumonia After
Allogeneic Hematopoietic Stem Cell Transplant: Report of Clinical Response
to Treatment with Tigecycline. Transpl Infect Dis.
2008 Oct 8.
Regnier S, et al.
Clinical Management of Rapidly Growing Mycobacterial
Cutaneous Infections in Patients After Mesotherapy. Clin
Infect Dis. 2009 Nov 1;49:1358-64.
Winthrop KL, Chang E, et al.
Nontuberculous Mycobacteria Infections and Anti-Tumor
Necrosis Factor-Alpha Therapy. Emerg Infect Dis.
2009 Oct;15:1556-61.
Authors
Michael D. Iseman, M.D.
|
www.antimicrobe.org